fbpx
October 1, 2020

Promoting Innovation in Medical Product Assessment: A Risk-based Framework for Evaluating Computational Models for Regulatory Decision-Making

Background Computational modeling and simulation (M&S) have been recognized as powerful tools in facilitating drug and medical device development and regulatory research, with the capability to […]
October 1, 2020

How to Safely Dispose of Unused or Expired Medicine (30 seconds) – Video Transcript

MUSIC: IN Narrator: Unused prescription opioid pain medicines can spell RISK, if they’re taken by someone they weren’t prescribed for. Or HARM, if accidentally taken by […]
October 1, 2020

How to Safely Dispose of Unused or Expired Medicine – Video Transcript

MUSIC: IN Narrator: Unused medicines can spell many things. RISK, if they’re taken by someone they weren’t prescribed for. HARM, if accidentally taken by a child […]
October 1, 2020

Drug Disposal: FDA’s Flush List for Certain Medicines

If you received specific disposal instructions from your healthcare provider (e.g., doctor, pharmacist) for your unused or expired medicine, you should follow those instructions to dispose of your […]
October 1, 2020

How to Safely Dispose of Unused or Expired Medicine (60 seconds) – Video Transcript

MUSIC: IN Narrator: Unused prescription opioid pain medicines can spell many things. RISK, if they’re taken by someone they weren’t prescribed for. HARM, if accidentally taken […]
October 1, 2020

Deshágase de manera segura de los medicamentos opioides antes de que puedan hacer daño – Transcripción

INICIO DE MÚSICA Narrador: Los medicamentos no utilizados pueden significar muchas cosas. RIESGO, si los toma una persona a la que no se les recetó. PELIGRO, […]
October 1, 2020

Renal Cell Carcinoma: Developing Drugs and Biologics for Adjuvant Treatment

Submit Comments by 12/01/2020 Although you can comment on any guidance at any time (see 21 CFR 10.115(g)(5)), to ensure that the FDA considers your comment […]
October 1, 2020

Bladder Cancer: Developing Drugs and Biologics for Adjuvant Treatment

Submit Comments by 12/01/2020 Although you can comment on any guidance at any time (see 21 CFR 10.115(g)(5)), to ensure that the FDA considers your comment […]
September 30, 2020

Coronavirus (COVID-19) Update: Daily Roundup September 30, 2020

For Immediate Release: September 30, 2020 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0